• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU 2.16% $21.80

NEUREN PHARMACEUTICALS LIMITED

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of trofinetide.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NEU 22:25 50 28K
22:25 Last post  Piton72 Comments Created with Sketch.  50  Views Created with Sketch.  28K 
NEU
Share Price
22:10 10K 4.5M
22:10 Last post  prodigy1 Comments Created with Sketch.  10K  Views Created with Sketch.  4.5M 
NEU
NEU chart
27 28 29
21:32 1.6K 858K
Metals & Mining SECTOR NEWS

Meet Sun Silver (ASX:SS1) - ASX's newest silver player based in Nevada, USA.

SS1
16 May 2024
SUN SILVER LIMITED
21:32 Last post  wingnpray Comments Created with Sketch.  1.6K  Views Created with Sketch.  858K 
NEU 21:02 64 32K
21:02 Last post  Tangentland Comments Created with Sketch.  64  Views Created with Sketch.  32K 
NEU
positive phase iii interim analysis ..big news
20:41 2 559
20:41 Last post  Tangentland Comments Created with Sketch.  2  Views Created with Sketch.  559 
NEU 20:06 7 2.8K
20:06 Last post  Guzz Comments Created with Sketch.  7  Views Created with Sketch.  2.8K 
NEU 18:13 33 14K
18:13 Last post  baldwidx Comments Created with Sketch.  33  Views Created with Sketch.  14K 
NEU
Acadia
8 9 10
07:06 545 241K
07:06 Last post  Brucekoala Comments Created with Sketch.  545  Views Created with Sketch.  241K 

See All Discussions arrow Created with Sketch.

Timeline

Neuren CEO to present at BIO & Jefferies conferences in US
16 May 11:25
 
Investor presentation, 15 May 2024
15 May 09:43
 
DAYBUE Q1 net sales US$75.9m, full-year guidance US$370-420m
09 May 10:09
 
Notification of cessation of securities - NEU
07 May 16:31
 
Notification of cessation of securities - NEU
26 Apr 16:40
 
Virtual AGM online guide
26 Apr 09:57
 
View More arrow Created with Sketch.
(20min delay)
Last
$21.80
Change
0.460(2.16%)
Mkt cap ! $2.783B
Open High Low Value Volume
$21.50 $22.27 $21.49 $17.34M 792.6K

Buyers (Bids)

No. Vol. Price($)
5 3550 $21.80
 

Sellers (Offers)

Price($) Vol. No.
$21.81 567 1
View Market Depth
Last trade - 16.10pm 16/05/2024 (20 minute delay) ?
Last
$21.85
  Change
0.460 ( 2.27 %)
Open High Low Volume
$21.56 $22.26 $21.50 182893
Last updated 15.59pm 16/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.